Matthew A Weissman, MD, MBA Email Matthew Weissman
- ASSOCIATE PROFESSOR | Medicine
- ASSOCIATE PROFESSOR | Pediatrics
- Internal Medicine
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Downtown Union Square 212-844-8100 212-844-8100
Book an Appointment - Matthew A Weissman, MD, MBA
Dr. Matthew A. Weissman is the Site Chair of the Department of Medicine at Mount Sinai Beth Israel Hospital and is Senior Faculty in both Internal Medicine and Pediatrics at the Icahn School of Medicine at Mount Sinai. As Chair, he is responsible for the clinical, educational, and research activities of the Department, which includes oversight of over 175 employed faculty and over 120 medical residents and postdoctoral fellows.
Previously, Dr. Weissman was the Chief Medical Officer of Community Healthcare Network (CHN), a major Federally Qualified Health Center network in New York City. In that role, he oversaw the quality of clinical care and the operations of 14 clinical sites in the organization, supervising departments including physicians, nurse practitioners, nursing, front desk staff, custodial, and nutrition. Under his leadership, CHN was able to expand both access to and quality of care, including winning the Health Center Quality Leaders Award three years in a row from the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services, which is the primary federal agency for improving health care to geographically isolated, economically or medically vulnerable populations. Following the passing of CHN’s President and CEO in May 2014, Dr. Weissman served as the organization’s Acting President and CEO until January 2015, during which time he helped create the first Nurse Practitioner fellowship program in New York State.
Dr. Weissman received an AB in Economics from Harvard University magna cum laude and a Medical Doctorate and Masters in Business Administration in Health Management from Tufts University. He completed his residency and chief residency at Mount Sinai Medical Center in New York and is Board Certified in both Internal Medicine and Pediatrics. He currently co-chairs the New York City Department of Health and Mental Hygiene’s Citywide Colon Cancer Control Coalition (C5). He was, until recently, the co-chair of the Clinical Quality Committee and the Cardiovascular Project Committee of the Mount Sinai Preferred Provider System (DSRIP PPS) and a member of the Boards of Directors of the Community Health Care Association of New York State (CHCANYS) and AmidaCare. He is a Fellow of the New York Academy of Medicine. His primary interests are the transition of pediatric to adult care, leveraging technology to streamline delivery and improve access to and quality of care, and training the next generation of physicians and medical leaders.
American Board of Pediatrics
American Board of Internal Medicine
- Annual Health Care Supervision
- Annual Physical
- Birth Control / Contraception
- Blood Work
- Fecal Occult Blood Test
- General Consultation
- Glycosylated Hemoglobin Test
- Hepatitis A Vaccine
- Hepatitis B Vaccine
- Herpes Zoster Vaccine
- High Blood Pressure
- High Cholesterol
- Hypertension (High Blood Pressure)
- Hypertension And Related Disorders
- Pertussis Vaccine
- Pneumococcal Vaccine
- Polio Vaccine
- Primary Care
- Sexually Transmitted Infections
- Sore Throat
- Tobacco Use Disorder
- Type 2 Diabetes
- Typhoid Vaccine
- Urinary Tract Infection
- Varicella Vaccine
- Viral Pharyngitis
- Vitamin B12 Deficiency
- Vitamin D Deficiency
Healthcare, Technology & Innovation
BA, Harvard University
MBA, Tufts University School of Medicine
MD, Tufts University School of Medicine
MD, Tufts University
Internship, Mount Sinai School of Medicine
Chief Resident, Mount Sinai School of Medicine
Residency, Mount Sinai School of Medicine
Residency, Internal Med./Peds.
Mount Sinai School of Medicine
Mount Sinai School of Medicine Department of Pediatrics
Magna Cum Laude
CARE for Children
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Weissman did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.